In-stent restenosis of drug-eluting stents

被引：10

作者：

Minha, Sa'ar ^{[1
,2
]}

Pichard, Augusto D. ^{[1
,2
]}

Waksman, Ron ^{[1
,2
]}

机构：

[1] MedStar Washington Hosp Ctr, Intervent Cardiol, Washington, DC USA

[2] MedStar Washington Hosp Ctr, Washington, DC 20010 USA

来源：

FUTURE CARDIOLOGY | 2013年 / 9卷 / 05期

关键词：

bare metal stent; drug-eluting stent; in-stent restenosis;

D O I：

10.2217/FCA.13.45

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Drug-eluting stents (DES) have emerged as an improved alternative to bare-metal stents by demonstrating reduced rates of restenosis and target lesion revascularization. This emergence has led to the unrestricted use of DES for various indications and lesions, and subsequently revealed DES in-stent restenosis as a novel interventional therapeutic dilemma. Recent insights regarding the pathophysiological processes and therapeutic alternatives have added to the accumulated knowledge regarding the appropriate approach to this phenomenon. This review aims to detail the mechanism and clinical presentation of, and therapeutic strategies for, the treatment of DES in in-stent restenosis.

引用

页码：721 / 731

页数：11

共 50 条

[21] Comparison of drug-eluting balloon with repeat drug-eluting stent for recurrent drug-eluting stent in-stent restenosis
Wang, Guozhong
Zhao, Quanming
Chen, Qing
Zhang, Xiaoxia
Tian, Lei
Zhang, Xiaojiang
CORONARY ARTERY DISEASE, 2019, 30 (07) : 473 - 480
[22] Kissing drug eluting balloons for in-stent restenosis complicating bifurcations treated with drug-eluting stents
Raja, Yogesh
Doshi, Sagar N.
Townend, Jonathan N.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2012, 79 (03) : 392 - 396
[23] Incidence and predictors of recurrent restenosis following implantation of drug-eluting stents for in-stent restenosis
Lee, Cheol Whan
Park, Chang-Bum
Kim, Young-Hak
Hong, Myeong-Ki
Kim, Jae-Joong
Park, Seong-Wook
Park, Seung-Jung
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2007, 69 (01) : 104 - 108
[24] Outcome Differences With the Use of Drug-Eluting Stents for the Treatment of In-Stent Restenosis of Bare-Metal Stents Versus Drug-Eluting Stents
Steinberg, Daniel H.
Gaglia, Michael A., Jr.
Slottow, Tina L. Pinto
Roy, Probal
Bonello, Laurent
De Labriolle, Axel
Lemesle, Gilles
Torguson, Rebecca
Kineshige, Kimberly
Xue, Zhenyi
Suddath, William O.
Kent, Kenneth M.
Satler, Lowell F.
Pichard, Augusto D.
Lindsay, Joseph
Waksman, Ron
AMERICAN JOURNAL OF CARDIOLOGY, 2009, 103 (04): : 491 - 495
[25] Evaluation and management of drug-eluting stent in-stent restenosis
Parfrey, Shane
Siu, Vincent J.
Graham, John
Vijayaraghavan, Ram
Li, Christopher
Pang, Jeffrey
Kalra, Sanjog
Dzavik, Vladimir C.
Wijeysundera, Harindra
Bagai, Akshay
CURRENT OPINION IN CARDIOLOGY, 2023, 38 (05) : 433 - 440
[26] Findings Supporting Drug Resistance in the Treatment of In-Stent Restenosis Within Drug-Eluting Stents
Byrne, Robert Albert
Mehilli, Julinda
Massberg, Steffen
Laugwitz, Karl-Ludwig
Pache, Juergen
Schoemig, Albert
Kastrati, Adnan
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B4 - B4
[27] Use of drug-eluting stents for the treatment of in-stent restenosis in routine clinical practice
Belardi, JA
Cura, F
Albertal, M
Padilla, L
Solioz, G
Balino, PP
Pascua, JA
Fava, C
Berrocal, D
Mendiz, O
Grinfeld, L
CORONARY ARTERY DISEASE, 2005, 16 (05) : 327 - 330
[28] Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis
Eisenberg, Mark J.
Konnyu, Kristin J.
AMERICAN JOURNAL OF CARDIOLOGY, 2006, 98 (03): : 375 - 382
[29] In-Stent Restenosis After Femoropopliteal Interventions With Drug-Eluting Stents Same But Different?
Sobieszczyk, Piotr
JACC-CARDIOVASCULAR INTERVENTIONS, 2016, 9 (08) : 835 - 837
[30] Management of in-stent restenosis - Intracoronary brachytherapy vs drug-eluting stents.
Sadiq, I
Athar, H
Ahmed, A
Papaioannou, G
Ashir, R
Ameti, L
Mennet, R
Kiernan, F
McKay, R
Elkoustaf, R
AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (6A): : 147E - 147E

← 1 2 3 4 5 →